Skip to main content

Annual charge exemptions (ACE) dataset

View annual charge exemptions (ACE) based on a sponsor declaring $0 turnover.

In order to ensure transparency about the availability of therapeutic goods in Australia, all entries in the ARTG that had not commenced generating turnover and were exempt from annual charges under the ACE scheme in previous financial years, are published on the TGA website annually under the authority of subsection 61 (5C) of the Therapeutic Goods Act 1989.

Exemptions published are for the 2023-2024 financial year.

You can view previous financial years exemptions on Trove.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Search

20385 result(s) found, displaying 19651 to 19675
  • Exempt from annual charge in 2023-24 due to Vitex Pharmaceuticals Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Zifam Pinnacle Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Vitex Pharmaceuticals Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Zifam Pinnacle Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Zifam Pinnacle Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Australia ASME Technology Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Nature's Bio Technology Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Live Young Supplements Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Live Young Supplements Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Procter & Gamble Australia Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Australian Health Vitality Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Probiomin Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to THG Aus Nutrition declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Metina Australia Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Littlecare Pharma Pty Ltd T/A Minerva Pharmaceuticals declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Greenfield Pharmaceutical Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Honour Health Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Mega Lifesciences (Australia) Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to JSHealth Vitamins Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to B Pure Australia Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Grace Biogen Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Grace Biogen Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Grace Biogen Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2023-24 due to Grace Biogen Pty Ltd declaring $0 turnover in that period.

Help us improve the Therapeutic Goods Administration site